Endogenous urinary monoamine oxidase inhibitor excretion in Parkinson's disease and other neurological disorders. [electronic resource]
- Journal of neural transmission. Parkinson's disease and dementia section 1989
- 263-8 p. digital
Publication Type: Journal Article
0936-3076
10.1007/BF02263480 doi
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine--metabolism Adult Aged Aged, 80 and over Female Humans Isatin Male Middle Aged Monoamine Oxidase Inhibitors--therapeutic use Nervous System Diseases--drug therapy Parkinson Disease--drug therapy